ATE464888T1 - Vorrichtung für die transdermale abgabe von wirkstoffen - Google Patents

Vorrichtung für die transdermale abgabe von wirkstoffen

Info

Publication number
ATE464888T1
ATE464888T1 AT05771775T AT05771775T ATE464888T1 AT E464888 T1 ATE464888 T1 AT E464888T1 AT 05771775 T AT05771775 T AT 05771775T AT 05771775 T AT05771775 T AT 05771775T AT E464888 T1 ATE464888 T1 AT E464888T1
Authority
AT
Austria
Prior art keywords
active ingredients
transdermal delivery
layer
water
delivery
Prior art date
Application number
AT05771775T
Other languages
English (en)
Inventor
Paolo Colombo
Patrizia Santi
Sara Nicoli
Cristina Padula
Fabio Marra
Original Assignee
Lisapharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34956372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE464888(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lisapharma Spa filed Critical Lisapharma Spa
Application granted granted Critical
Publication of ATE464888T1 publication Critical patent/ATE464888T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05771775T 2004-07-23 2005-07-22 Vorrichtung für die transdermale abgabe von wirkstoffen ATE464888T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001492A ITMI20041492A1 (it) 2004-07-23 2004-07-23 Nuovo dispositivo per il rilascio di principi attivi
PCT/EP2005/053581 WO2006008320A2 (en) 2004-07-23 2005-07-22 Device for transdermal delivery of active principles

Publications (1)

Publication Number Publication Date
ATE464888T1 true ATE464888T1 (de) 2010-05-15

Family

ID=34956372

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05771775T ATE464888T1 (de) 2004-07-23 2005-07-22 Vorrichtung für die transdermale abgabe von wirkstoffen

Country Status (9)

Country Link
US (1) US20080292684A1 (de)
EP (1) EP1789025B1 (de)
JP (1) JP2008507495A (de)
AT (1) ATE464888T1 (de)
CA (1) CA2574682A1 (de)
DE (1) DE602005020811D1 (de)
ES (1) ES2344912T3 (de)
IT (1) ITMI20041492A1 (de)
WO (1) WO2006008320A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7629384B2 (en) * 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US9050365B2 (en) 2004-04-19 2015-06-09 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
US20070264487A1 (en) * 2006-05-12 2007-11-15 Dean Georgiades Treated film strips
US20090297591A1 (en) * 2008-05-30 2009-12-03 Orient Pharma Co., Ltd. Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds
EP3045171A1 (de) 2009-06-24 2016-07-20 Strategic Science & Technologies, LLC Topische zusammensetzung
US12138268B2 (en) * 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US11684624B2 (en) * 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
WO2010151241A1 (en) 2009-06-24 2010-12-29 Strategic Science & Technologies, Llc Topical composition containing naproxen
CN103442723A (zh) 2010-12-29 2013-12-11 战略科学与技术有限责任公司 治疗变态反应和其它适应症的系统和方法
CN105920603B (zh) * 2010-12-29 2022-02-11 战略科学与技术有限责任公司 勃起功能障碍和其它适应症的治疗
EP2697492B1 (de) 2011-04-11 2017-09-27 Alliqua, Inc. Transdermale pflaster mit durch ionisierte strahlung vernetzten polymeren und verbesserten freisetzungseigenschaften
ITMI20111355A1 (it) * 2011-07-20 2013-01-21 Epifarma Srl Cerotto transdermico contenente diclofenac e tiocolchicoside
US20140302118A1 (en) * 2011-08-25 2014-10-09 Nipro Patch Co., Ltd. Hydrous adhesive skin patch
JP5307931B1 (ja) * 2012-12-27 2013-10-02 久光製薬株式会社 貼付剤及びその製造方法
CN105209084B (zh) 2013-03-13 2018-07-03 艾利丹尼森公司 改善的粘合性能
CN104758181A (zh) * 2015-04-09 2015-07-08 史祎 一种无溶剂贴敷剂制备工艺
WO2018006069A1 (en) * 2016-06-30 2018-01-04 Teva Pharmaceuticals International Gmbh Improved formulations for transdermal pharmaceutical systems
AU2018230356A1 (en) * 2017-03-08 2019-10-24 Baxter Healthcare Sa Device for delivery of powdered hemostatic agents
WO2019059377A1 (ja) * 2017-09-22 2019-03-28 株式会社 メドレックス 再貼付不可能な貼付剤
AU2020315758B2 (en) 2019-07-16 2024-08-01 Donaghys Limited Transdermal solvent system and methods of use
KR102743652B1 (ko) * 2021-02-25 2024-12-17 한국원자력연구원 항암 효과를 갖는 하이드로겔 및 이의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3827561C1 (de) * 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
JPH07265352A (ja) * 1994-03-31 1995-10-17 Sekisui Chem Co Ltd 貼付剤
IT1319210B1 (it) 2000-10-13 2003-09-26 Italiano Biochimico Lisapharma Pellicola per la somministrazione dermica e transdermica di principiattivi.
US20050113510A1 (en) * 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US6887291B2 (en) 2001-08-30 2005-05-03 Tda Research, Inc. Filter devices and methods for carbon nanomaterial collection

Also Published As

Publication number Publication date
CA2574682A1 (en) 2006-01-26
US20080292684A1 (en) 2008-11-27
EP1789025B1 (de) 2010-04-21
DE602005020811D1 (de) 2010-06-02
ITMI20041492A1 (it) 2004-10-23
ES2344912T3 (es) 2010-09-09
WO2006008320A2 (en) 2006-01-26
WO2006008320A3 (en) 2006-05-04
JP2008507495A (ja) 2008-03-13
EP1789025A2 (de) 2007-05-30

Similar Documents

Publication Publication Date Title
ATE464888T1 (de) Vorrichtung für die transdermale abgabe von wirkstoffen
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
WO2007070649A3 (en) Antimicrobial coating system
MEP23508A (en) Compositions and methods for comtrolling drug loss and delivery in transdermal drug delivery systems
MY144351A (en) Gel adhesive compositions, method of making, and use thereof
ATE455563T1 (de) Zusammensetzungen für die gewebeadhäsion
WO2006009987A3 (en) Dissolvable film composition
DK1957130T3 (da) Hydrofilt overtræk omfattende en polyelektrolyt
AR097045A2 (es) Sistema terapéutico transdérmico
ATE369825T1 (de) Wundauflage
WO2007041584A3 (en) Implantable sensors, implantable pumps, and anti-scarring drug combinations
ATE389385T1 (de) Ophthalmische depot-formulierungen zur periokkularen oder subkonjunktivalen verabreichung
EA200901112A1 (ru) Жидкие композиции, образующие дермальные пленки, для введения лекарственных препаратов в кожу
WO2006013337A3 (en) Tissue-adhesive materials
ATE288743T1 (de) Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist
WO2005055973A3 (de) Endoparasitizide mittel zur topischen applikation
DE60118395D1 (de) Pharmazeutische zusammensetzungen mit verzögerter freisetzung für die parenterale applikation von hydrophilen wirkstoffen
NZ588883A (en) Permeant delivery system and methods for use thereof
WO2002024159A3 (en) Implantable drug delivery patch
WO2007130841A3 (en) Oral compositions comprising siloxane polymers
WO2008005458A3 (en) Delivery device having self-assembling dendritic polymers and method of use thereof
TW200514590A (en) Hydrophilic adhesives for delivery of herbal medicines
EA201001244A1 (ru) Система доставки лекарственного средства со стабилизирующим эффектом
BRPI0411752A (pt) implantes subcutáneos apresentando liberação inicial limitada do princìpio ativo e liberação ampliada subseqüente linearmente variável do mesmo
DE50115451D1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties